197 related articles for article (PubMed ID: 17918294)
1. Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens.
Nagy V; Todor N; Coza O; Ordeanu C; Ghilezan N
J BUON; 2007; 12(3):389-94. PubMed ID: 17918294
[TBL] [Abstract][Full Text] [Related]
2. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
Serkies K; Jassem J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
[TBL] [Abstract][Full Text] [Related]
3. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
Torres MA; Jhingran A; Thames HD; Levenback CF; Bodurka DC; Ramondetta LM; Eifel PJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):118-25. PubMed ID: 17869451
[TBL] [Abstract][Full Text] [Related]
4. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
McQuellon RP; Thaler HT; Cella D; Moore DH
Gynecol Oncol; 2006 May; 101(2):296-304. PubMed ID: 16376417
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India.
Saibishkumar EP; Patel FD; Sharma SC
Bull Cancer; 2005 Jan; 92(1):E7-12. PubMed ID: 15811845
[TBL] [Abstract][Full Text] [Related]
7. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.
Monk BJ; Huang HQ; Cella D; Long HJ;
J Clin Oncol; 2005 Jul; 23(21):4617-25. PubMed ID: 15911864
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
Long HJ; Bundy BN; Grendys EC; Benda JA; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
J Clin Oncol; 2005 Jul; 23(21):4626-33. PubMed ID: 15911865
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of intra-arterial chemotherapy versus intra-arterial chemotherapy and gelfoam embolization for treatment of advanced cervical carcinoma.
Ikeda O; Mizukami N; Murata Y; Arakawa A; Katabuchi H; Okamoto H; Yasunaga T; Tsunawaki A; Yamashita Y
Cardiovasc Intervent Radiol; 2005; 28(6):736-43. PubMed ID: 16132387
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
[TBL] [Abstract][Full Text] [Related]
13. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
[TBL] [Abstract][Full Text] [Related]
14. Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.
Ohno T; Kato S; Wakatsuki M; Noda SE; Murakami C; Nakamura M; Tsujii H
Gynecol Oncol; 2006 Oct; 103(1):94-9. PubMed ID: 16527337
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
[TBL] [Abstract][Full Text] [Related]
16. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results.
Veerasarn V; Lorvidhaya V; Kamnerdsupaphon P; Suntornpong N; Sangruchi S; Lertsanguansinchai P; Khorprasert C; Sookpreedee L; Udompunturak S
Gynecol Oncol; 2007 Jan; 104(1):15-23. PubMed ID: 16996583
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality therapy of locally advanced cervical cancer.
Rose PG
J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
[TBL] [Abstract][Full Text] [Related]
19. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sobel E; Rose GS; Thomas G; Carlson JW
Gynecol Oncol; 2004 Aug; 94(2):495-501. PubMed ID: 15297194
[TBL] [Abstract][Full Text] [Related]
20. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
Jones EL; Samulski TV; Dewhirst MW; Alvarez-Secord A; Berchuck A; Clarke-Pearson D; Havrilesky LJ; Soper J; Prosnitz LR
Cancer; 2003 Jul; 98(2):277-82. PubMed ID: 12872345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
